NASDAQ:EYEN - Eyenovia Stock Price, Price Target & More

$8.60 +0.10 (+1.18 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$8.50
Today's Range$8.60 - $9.00
52-Week Range$7.32 - $10.74
Volume12,792 shs
Average Volume19,808 shs
Market Capitalization$87.53 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Eyenovia (NASDAQ:EYEN)

Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst that has completed Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat that has completed Phase II clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.

Receive EYEN News and Ratings via Email

Sign-up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EYEN
CUSIPN/A
Phone917-289-1117

Debt

Debt-to-Equity RatioN/A
Current Ratio9.60%
Quick Ratio9.60%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.51 per share
Price / Book16.86

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares9,940,000

How to Become a New Pot Stock Millionaire

Eyenovia (NASDAQ:EYEN) Frequently Asked Questions

What is Eyenovia's stock symbol?

Eyenovia trades on the NASDAQ under the ticker symbol "EYEN."

How were Eyenovia's earnings last quarter?

Eyenovia Inc. (NASDAQ:EYEN) released its quarterly earnings data on Monday, April, 2nd. The company reported ($0.84) earnings per share for the quarter, missing analysts' consensus estimates of ($0.34) by $0.50. View Eyenovia's Earnings History.

When is Eyenovia's next earnings date?

Eyenovia is scheduled to release their next quarterly earnings announcement on Wednesday, May, 9th 2018. View Earnings Estimates for Eyenovia.

What price target have analysts set for EYEN?

2 brokers have issued 12 month price targets for Eyenovia's shares. Their forecasts range from $20.00 to $35.00. On average, they anticipate Eyenovia's share price to reach $27.50 in the next year. View Analyst Ratings for Eyenovia.

Who are some of Eyenovia's key competitors?

Who are Eyenovia's key executives?

Eyenovia's management team includes the folowing people:
  • Dr. Tsontcho Ianchulev M.P.H., M.D., MPH, CEO, Chief Medical Officer, MD & Director (Age 44)
  • Mr. John P. Gandolfo, CFO, Principal Accounting Officer & Sec. (Age 57)
  • Ms. Jennifer Clasby, VP of Clinical Operations (Age 64)
  • Mr. Luke Clauson, VP of R&D (Age 39)

When did Eyenovia IPO?

(EYEN) raised $30 million in an IPO on Thursday, January 25th 2018. The company issued 2,700,000 shares at $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners​ served as the underwriters for the IPO.

When did the company's quiet period expire?

Eyenovia's quiet period expired on Tuesday, March 6th. Eyenovia had issued 2,730,000 shares in its public offering on January 25th. The total size of the offering was $27,300,000 based on an initial share price of $10.00. During the company's quiet period, underwriters and any insiders involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Has Eyenovia been receiving favorable news coverage?

Press coverage about EYEN stock has been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Eyenovia earned a daily sentiment score of 0.21 on Accern's scale. They also gave news headlines about the company an impact score of 44.94 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Eyenovia's major shareholders?

Eyenovia's stock is owned by many different of retail and institutional investors. Top institutional investors include ESHELMAN FREDRIC N (15.00%) and ESHELMAN FREDRIC N (15.00%). View Institutional Ownership Trends for Eyenovia.

How do I buy shares of Eyenovia?

Shares of EYEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Eyenovia's stock price today?

One share of EYEN stock can currently be purchased for approximately $8.60.

How big of a company is Eyenovia?

Eyenovia has a market capitalization of $87.53 million. The company earns $-5,120,000.00 in net income (profit) each year or ($2.19) on an earnings per share basis.

How can I contact Eyenovia?

Eyenovia's mailing address is 501 Fifth Avenue Suite 1404, New York NY, 10017. The company can be reached via phone at 917-289-1117 or via email at [email protected]


MarketBeat Community Rating for Eyenovia (EYEN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  11 (Vote Outperform)
Underperform Votes:  12 (Vote Underperform)
Total Votes:  23
MarketBeat's community ratings are surveys of what our community members think about Eyenovia and other stocks. Vote "Outperform" if you believe EYEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EYEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Eyenovia (NASDAQ:EYEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Eyenovia in the last 12 months. Their average twelve-month price target is $27.50, suggesting that the stock has a possible upside of 219.77%. The high price target for EYEN is $35.00 and the low price target for EYEN is $20.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $27.50$27.50N/AN/A
Price Target Upside: 219.77% upside205.56% upsideN/AN/A

Eyenovia (NASDAQ:EYEN) Consensus Price Target History

Price Target History for Eyenovia (NASDAQ:EYEN)

Eyenovia (NASDAQ:EYEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/20/2018Ladenburg ThalmannInitiated CoverageBuy -> Buy$35.00MediumView Rating Details
2/20/2018Roth CapitalInitiated CoverageBuy -> Buy$20.00HighView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Eyenovia (NASDAQ:EYEN) Earnings History and Estimates Chart

Earnings by Quarter for Eyenovia (NASDAQ:EYEN)

Eyenovia (NASDAQ:EYEN) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.7 EPS

Eyenovia (NASDAQ EYEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018($0.38)N/AView Earnings Details
4/2/2018Q4 2017($0.34)($0.84)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Eyenovia (NASDAQ:EYEN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Eyenovia (NASDAQ EYEN) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.05%
Insider Trading History for Eyenovia (NASDAQ:EYEN)

Eyenovia (NASDAQ EYEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Fredric N EshelmanDirectorBuy335,000$10.00$3,350,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Eyenovia (NASDAQ EYEN) News Headlines

Source:
DateHeadline
Eyenovia (EYEN) Raised to "Buy" at Zacks Investment ResearchEyenovia (EYEN) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 24 at 10:46 PM
Eyenovia, Inc. (EYEN) Sees Hammer Chart Pattern: Time to Buy?Eyenovia, Inc. (EYEN) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - April 24 at 3:22 PM
Eyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial ResultsEyenovia Announces Conference Call and Webcast for First Quarter 2018 Financial Results
finance.yahoo.com - April 19 at 3:22 PM
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Eyenovia, Inc. Investors (EYEN)Glancy Prongay & Murray LLP Announces Investigation on Behalf of Eyenovia, Inc. Investors (EYEN)
finance.yahoo.com - April 11 at 7:13 AM
Eyenovia CEO Talks Temporary Distraction Of IPO, Pipeline OpportunityEyenovia CEO Talks Temporary Distraction Of IPO, Pipeline Opportunity
www.benzinga.com - April 9 at 3:19 PM
Eyenovia (EYEN) Issues  Earnings ResultsEyenovia (EYEN) Issues Earnings Results
www.americanbankingnews.com - April 3 at 7:45 AM
BRIEF-Eyenovia Reports Q4 Loss Per Share $0.84BRIEF-Eyenovia Reports Q4 Loss Per Share $0.84
www.reuters.com - April 2 at 3:20 PM
Eyenovia Inc (EYEN) Reports Q4 Loss of $0.84Eyenovia Inc (EYEN) Reports Q4 Loss of $0.84
www.streetinsider.com - April 2 at 7:05 AM
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial ResultsEyenovia Announces Conference Call and Webcast for Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 19 at 3:17 PM
Eyenovia to Present at the 30th Annual ROTH ConferenceEyenovia to Present at the 30th Annual ROTH Conference
finance.yahoo.com - February 27 at 3:16 PM
Eyenovia Incs (EYEN) Quiet Period To End  on March 6thEyenovia Inc's (EYEN) Quiet Period To End on March 6th
www.americanbankingnews.com - February 27 at 1:02 AM
Eyenovia (EYEN) Advances MicroPine for Myopia into Phase III Clinical DevelopmentEyenovia (EYEN) Advances MicroPine for Myopia into Phase III Clinical Development
www.streetinsider.com - February 23 at 5:30 AM
Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering CommitteeEyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee
finance.yahoo.com - February 21 at 3:15 PM
Eyenovia (EYEN) Coverage Initiated at Roth CapitalEyenovia (EYEN) Coverage Initiated at Roth Capital
www.americanbankingnews.com - February 20 at 11:18 AM
Eyenovia (EYEN) Coverage Initiated by Analysts at Ladenburg Thalmann Financial ServicesEyenovia (EYEN) Coverage Initiated by Analysts at Ladenburg Thalmann Financial Services
www.americanbankingnews.com - February 20 at 10:30 AM
Insider Buying: Eyenovia Inc (EYEN) Director Buys 335,000 Shares of StockInsider Buying: Eyenovia Inc (EYEN) Director Buys 335,000 Shares of Stock
www.americanbankingnews.com - February 6 at 12:24 PM
Eyenovia Plans $30 Million IPO for Week of January 22nd (EYEN)Eyenovia Plans $30 Million IPO for Week of January 22nd (EYEN)
www.americanbankingnews.com - January 10 at 1:04 AM

SEC Filings

Eyenovia (NASDAQ:EYEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Eyenovia (NASDAQ EYEN) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.